BC Week In Review | Oct 14, 2013
Company News

Diagnovus sales and marketing update

Diagnovus launched the Engauge-GI-Barrett's Esophagus gene expression assay diagnostic tool worldwide to aid in predicting the risk of progression to high-grade dysplasia or esophageal adenocarcinoma in Barrett's Esophagus patients. The RT-PCR assay, conducted on formalin-fixed,...
Items per page:
1 - 1 of 1